Quantcast
Article Index |Advertise | Mobile | RSS | Wireless | Newsletter | Archive | Corrections | Syndication | Contact us | About Us| Services
 
  Breaking News :    
Advertisement
Century Properties
Geo Estate

INQUIRER ALERT
Get the free INQUIRER newsletter
Enter your email address:

 
Inquirer Lifestyle Type Size: (+) (-)
You are here: Home > Showbiz & Style > Inquirer Lifestyle

  ARTICLE SERVICES      
     Reprint this article     Print this article  
    Send Feedback  
    Post a comment   Share  

  RELATED STORIES  




imns



Diving savants scour seas for medical cure

By Tessa Salazar
Philippine Daily Inquirer
First Posted 20:09:00 05/16/2008

Filed Under: Health, Medicines

(Conclusion)

MANILA, Philippines?The diving scientists aren?t just there to observe. Part of the research method is to take samples of the sponges and snails back to the lab, where they would be analyzed.

Sea sponges, the scientists said, are easier to collect. Some turrid snails, however, could only be found at depths of at least 120 feet. For this task, they have utilized trawlers or fishing boats with nets to collect the snails.

Attractive subject of studies

Noting that the Philippines is known to be the center of turrid biodiversity in the world, the team also explained that little is yet known about turrids, making them an attractive subject of intensive, pioneering studies.

Turrids produce peptide toxins which they use to hunt, paralyze and feed on their primary prey?polychaete worms. This hunting and feeding behavior is considered by the team as representing an ?extremely valuable ecological lead for them to discover novel neuroactive peptides from turrids that could be developed into sedatives and pain killers.?

The first marine-sourced drug ever to be approved in the United States and Europe?the pain killer known as Prialt or Ziconotide?is based on a peptide toxin first isolated and characterized from a Conus snail from the Philippines by the research group of Dr. Baldomero M. Olivera at the University of Utah in the mid-?80s.

Olivera is a collaborator of the Pharma Seas Program.

Pain management

The team stressed pain management as an ?important aspect? of patient care, especially those afflicted with terminal diseases such as cancer.

?The new paradigm of health care and treatment of disease involves a humane or compassionate approach to dealing with sensory pain and discomfort.?

Scientists in the program said that marine microorganisms can be cultured in the laboratory and provide a sufficient source of bioactive compounds for further development studies without having to recollect and deplete the natural source from the wild.

Perry Aliño believes that his team is on track to find breakthrough treatments from under the sea. Indeed, he would not be surprised if the lowliest of sea creatures would reveal life-saving compounds?in a place where all life began.



Copyright 2012 Philippine Daily Inquirer. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.

Factual errors? Contact the Philippine Daily Inquirer's day desk.
Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate.
Or write The Readers' Advocate:

c/o Philippine Daily Inquirer
Chino Roces Avenue corner Yague and Mascardo Streets,
Makati City, Metro Manila, Philippines
Or fax nos. +63 2 8974793 to 94


Share

RELATED STORIES:

OTHER STORIES:

COLUMNS:


  ^ Back to top

© Copyright 2001-2012 INQUIRER.net, An INQUIRER Company

The INQUIRER Network: HOME | NEWS | SPORTS | SHOWBIZ & STYLE | TECHNOLOGY | BUSINESS | OPINION | GLOBAL NATION | Site Map
Services: Advertise | Buy Content | Wireless | Newsletter | Low Graphics | Search / Archive | Article Index | Contact us
The INQUIRER Company: About the Inquirer | User Agreement | Link Policy | Privacy Policy

Advertisement
Inquirer VDO
Property Guide
ABS-CBN TFC
DZIQ 990